Working in the pharmaceutical space, I’ve witnessed firsthand how biosimilars have shifted from a theoretical disruption to a real force reshaping market dynamics. Whether you’re on the innovator side trying to protect share or part of a biosimilar team plotting…

When I first started working in the rare disease and gene therapy space, I thought the science would be the hardest part to wrap my head around. And don’t get me wrong—it’s complex. But what I didn’t fully appreciate at…

I’ll admit it—there was a time when neuroscience felt like a graveyard of pharma ambitions. I remember the wave of program terminations, the clinical failures, and the retreat from Alzheimer’s and Parkinson’s pipelines that felt almost industry wide. For a…

Picture this: You’re in a high-stakes chess match. The room is silent. The tension is thick. Every move counts. But instead of thinking ahead, you’re fixated on where your opponent used to be five turns ago. You can guess what…

Competitive intelligence in biotech and pharma isn’t just about tracking pipeline developments—it’s a high-stakes game where missing a key move can cost billions. Yet, time and again, companies fail to anticipate threats because they focus only on obvious competitors, outdated…

A Preview of My Upcoming Talk: Presenting Pricing Insights That Resonate with Leaders Pricing strategies often rely on robust data—carefully researched, meticulously analyzed, and expertly compiled. Yet, even the most data-driven pricing recommendations can be met with hesitation, skepticism, or…

Introduction Background Drug pricing reform in the U.S., driven by legislative changes such as the Inflation Reduction Act (IRA) and ongoing policy initiatives, is set to significantly alter the pharmaceutical competitive landscape. These changes will influence market access, pricing strategies,…

After spending two decades in the pharmaceutical industry, I’ve seen companies struggle to stay ahead of competitors, anticipate market shifts, and adapt to unexpected threats. Just like football, the industry is a high-stakes, fast-moving game, where misreading the competition or…

Introduction Background CGMs have emerged as critical tools in diabetes management, enabling real-time tracking of glucose levels and improving patient outcomes. With the rise of digital health integration, AI- driven analytics, and expanding use cases beyond diabetes management, the CGM…